Emerging Leaders: Future of Generative AI/LLMS in Life Sciences
12:30 PM – 1:15 PM | West Red Level, Suite 81
A discussion on what our industry is doing with Artificial intelligence now and where we are going with the wide release of new models. We will present some exciting existing solutions using AI and hear how they came to be. Then we will delve into theoretical short- and long-term uses of the various types that have become popular recently.
Ashwini Ghogare is the Head of AI and Automation for Drug Discovery, in the Global Science and Technology Group at Merck KGaA, responsible for setting up the AI-powered drug discovery and automation portfolio as an intrapreneurial venture across Life Science & Healthcare. Ashwini is a leader in transformational drug discovery echnologies with extensive experience in software development, new business incubation, and software product sales. Ashwini has previously, led strategic initiatives to identify transformative AI technologies for drug discovery applications and successfully build and launched a new AI-powered drug design solution, AIDDISON™. She was also responsible for the global services and commercial licensing of Synthia™, MilliporeSigma’s flagship retrosynthesis software product. She has a Ph.D. in organic chemistry in photobiology focused on the photochemical drug delivery system that led to the creation of a start-up, SingletO2 Therapeutics LLC.